Pine Valley Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
4,490
-9
-0.2% -$3.08K 0.06% 246
2026
Q1
$1.58M Sell
4,499
-36
-0.8% -$12.8K 0.07% 233
2025
Q4
$1.48M Sell
4,535
-73
-2% -$23.2K 0.07% 230
2025
Q3
$1.3M Buy
4,608
+18
+0.4% +$5.22K 0.06% 245
2025
Q2
$1.28M Sell
4,590
-179
-4% -$50.7K 0.07% 241
2025
Q1
$1.49M Sell
4,769
-144
-3% -$42.5K 0.09% 217
2024
Q4
$1.28M Buy
4,913
+204
+4% +$60.5K 0.08% 216
2024
Q3
$1.52M Sell
4,709
-43
-0.9% -$14.1K 0.09% 200
2024
Q2
$1.48M Sell
4,752
-237
-5% -$69.6K 0.1% 198
2024
Q1
$1.42M Sell
4,989
-39
-0.8% -$11.4K 0.1% 194
2023
Q4
$1.45M Buy
5,028
+568
+13% +$155K 0.1% 183
2023
Q3
$1.2M Sell
4,460
-184
-4% -$45.9K 0.11% 187
2023
Q2
$1.03M Buy
4,644
+2,755
+146% +$639K 0.1% 189
2023
Q1
$443K Buy
+1,889
New +$464K 0.07% 192

Other funds holding AMGN

Pine Valley Investments's AMGN Position: Q2 2026 in Review

Pine Valley Investments reduced its Amgen (AMGN) stake by 0.2% in Q2 2026, selling an estimated $3.08K and leaving 4,490 shares worth $1.63M. The position accounts for 0.06% of the portfolio, ranked #246.

Pine Valley Investments first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 1,825 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pine Valley Investments held 4,490 shares of Amgen worth $1.63M as of Q2 2026.
  • Pine Valley Investments sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
  • Amgen made up 0.06% of Pine Valley Investments's portfolio in Q2 2026, its #246 holding.
  • Pine Valley Investments first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 1,825 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.